Search results

A new era of high and volatile food prices is causing life-changing shifts in society, according to Oxfam and the Institute of Development Studies (IDS) in a joint report published today.

Wealthy nations representing just 13 percent of the world’s population have already cornered more than half (51 percent) of the promised doses of leading COVID-19 vaccine candidates, Oxfam warned today as the health and finance ministers of G20 countries meet to discuss the global pandemic. 

Wealthy nations are expected to fall up to $75 billion short of fulfilling their long-standing pledge to mobilize $100 billion each year from 2020 to 2025 to help the most vulnerable countries adapt to the dangerous effects of climate change and reduce their emissions, according to estimates by Oxfam today.

Today, the European Commission presented its proposal for new sources of revenue for the EU’s budget.  

A European tax on financial transactions would be fair, practical and popular and could raise as much as €210 billion to tackle poverty and climate change, according to Oxfam's new report.

The COVID-19 pandemic and the Thai government’s immediate responses have significantly affected workers and small-scale producers in the seafood sector. This briefing note identifies these impacts, offers reflections on the remaining challenges and further measures to support small-scale producers and workers during the ongoing pandemic.

Domestic Revenue Mobilisation is key for governments to fund their own development goals, finance gender-responsive public services and to reduce economic, social and gender inequalities. While the EU is leading the way when it comes to the quantity of aid it provides towards domestic revenue mobilisation, there is significant room for improvement when it comes to the quality of the aid provided.

The European Union, which holds eight seats out of twenty four on the International Monetary Fund (IMF) board, has made an offer to rotate some of their IMF board seats with middle-income countries

Big Pharma — long-blasted for gouging prices, avoiding taxes, and rigging the political process to maximize profits — has emerged as key players in the race to bring an end to the COVID-19 crisis. Who gets access to lifesaving medicines and vaccines — and when — will determine who lives and who dies.

European aid to poor countries is stalling two years ahead of the UN Millennium Development Goals deadline, with aid cut or stagnant in 19 member states, reveals the new Concord AidWatch report.